HEADER INHIBITOR/APOPTOSIS 18-AUG-06 2I3H TITLE STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A 4-MER PEPTIDE (AVPW) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ML-IAP RESIDUES 63-172; COMPND 5 SYNONYM: KIDNEY INHIBITOR OF APOPTOSIS PROTEIN, KIAP, MELANOMA COMPND 6 INHIBITOR OF APOPTOSIS PROTEIN, ML-IAP, LIVIN; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: AVPW PEPTIDE; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BIRC7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: CHEMICALLY SYNTHESIZED PEPTIDE KEYWDS ZINC BINDING, PEPTIDE COMPLEX, APOPTOSIS INHIBITION, PEPTIDOMIMETIC, KEYWDS 2 SMALL MOLECULE, DRUG DESIGN, INHIBITOR-APOPTOSIS COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.J.FAIRBROTHER,M.C.FRANKLIN REVDAT 4 03-APR-24 2I3H 1 REMARK REVDAT 3 21-FEB-24 2I3H 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2I3H 1 VERSN REVDAT 1 19-SEP-06 2I3H 0 JRNL AUTH K.ZOBEL,L.WANG,E.VARFOLOMEEV,M.C.FRANKLIN,L.O.ELLIOTT, JRNL AUTH 2 H.J.WALLWEBER,D.C.OKAWA,J.A.FLYGARE,D.VUCIC,W.J.FAIRBROTHER, JRNL AUTH 3 K.DESHAYES JRNL TITL DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF A POTENT SMAC JRNL TITL 2 MIMETIC THAT SENSITIZES CANCER CELLS TO APOPTOSIS BY JRNL TITL 3 ANTAGONIZING IAPS. JRNL REF ACS CHEM.BIOL. V. 1 525 2006 JRNL REFN ISSN 1554-8929 JRNL PMID 17168540 JRNL DOI 10.1021/CB600276Q REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.VUCIC,M.C.FRANKLIN,H.J.WALLWEBER,K.DAS,B.P.ECKELMAN, REMARK 1 AUTH 2 H.SHIN,L.O.ELLIOTT,K.DESHAYES,G.S.SALVESEN,W.J.FAIRBROTHER REMARK 1 TITL ENGINEERING ML-IAP TO PRODUCE AN EXTRAORDINARILY POTENT REMARK 1 TITL 2 CASPASE-9 INHIBITOR: IMPLICATIONS FOR SMAC-DEPENDENT REMARK 1 TITL 3 ANTI-APOPTOTIC ACTIVITY OF ML-IAP REMARK 1 REF BIOCHEM.J. V. 385 11 2005 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 15485396 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.C.FRANKLIN,S.KADKHODAYAN,H.ACKERLY,D.ALEXANDRU, REMARK 1 AUTH 2 M.D.DISTEFANO,L.O.ELLIOTT,J.A.FLYGARE,D.VUCIC,K.DESHAYES, REMARK 1 AUTH 3 W.J.FAIRBROTHER REMARK 1 TITL STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF REMARK 1 TITL 2 MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) REMARK 1 REF BIOCHEMISTRY V. 42 8223 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12846571 REMARK 1 DOI 10.1021/BI034227T REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 3 NUMBER OF REFLECTIONS : 30666 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1631 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.62 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.66 REMARK 3 REFLECTION IN BIN (WORKING SET) : 876 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1562 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.64000 REMARK 3 B22 (A**2) : -0.64000 REMARK 3 B33 (A**2) : 1.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.098 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.075 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.049 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.519 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1643 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1365 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2218 ; 1.132 ; 1.924 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3180 ; 0.748 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 189 ; 4.523 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 209 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1820 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 373 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 345 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1497 ; 0.234 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 787 ; 0.080 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 149 ; 0.201 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 8 ; 0.097 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 61 ; 0.230 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 29 ; 0.193 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 964 ; 1.421 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1527 ; 2.176 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 679 ; 1.842 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 691 ; 2.679 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 1643 ; 0.866 ; 2.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 233 ; 1.038 ; 2.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 1574 ; 1.131 ; 2.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 78 A 167 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 85.0510 68.2760 22.8770 REMARK 3 T TENSOR REMARK 3 T11: 0.1463 T22: 0.1593 REMARK 3 T33: 0.1706 T12: 0.0051 REMARK 3 T13: 0.0219 T23: 0.0076 REMARK 3 L TENSOR REMARK 3 L11: 1.7484 L22: 3.3420 REMARK 3 L33: 1.3936 L12: -0.3910 REMARK 3 L13: -0.3016 L23: -0.3056 REMARK 3 S TENSOR REMARK 3 S11: 0.0480 S12: 0.1506 S13: -0.0254 REMARK 3 S21: -0.2540 S22: -0.0659 S23: -0.0459 REMARK 3 S31: 0.0622 S32: -0.0148 S33: 0.0179 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 78 B 171 REMARK 3 RESIDUE RANGE : B 1001 B 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 78.3200 59.7820 50.7690 REMARK 3 T TENSOR REMARK 3 T11: 0.1586 T22: 0.1371 REMARK 3 T33: 0.1561 T12: 0.0038 REMARK 3 T13: 0.0128 T23: 0.0018 REMARK 3 L TENSOR REMARK 3 L11: 1.0254 L22: 2.2785 REMARK 3 L33: 1.1599 L12: 0.0350 REMARK 3 L13: 0.3578 L23: -0.9744 REMARK 3 S TENSOR REMARK 3 S11: -0.0176 S12: -0.0958 S13: 0.0118 REMARK 3 S21: 0.1842 S22: 0.0045 S23: 0.0035 REMARK 3 S31: -0.0581 S32: -0.0431 S33: 0.0131 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 4 REMARK 3 ORIGIN FOR THE GROUP (A): 79.4020 61.9370 15.3420 REMARK 3 T TENSOR REMARK 3 T11: 0.1117 T22: 0.1846 REMARK 3 T33: 0.1126 T12: 0.0704 REMARK 3 T13: -0.0164 T23: -0.0191 REMARK 3 L TENSOR REMARK 3 L11: -0.6556 L22: 6.2083 REMARK 3 L33: 18.4355 L12: -2.1066 REMARK 3 L13: -5.9624 L23: 2.8157 REMARK 3 S TENSOR REMARK 3 S11: -0.4310 S12: 1.0442 S13: -0.7925 REMARK 3 S21: 0.0642 S22: 0.1213 S23: 0.7165 REMARK 3 S31: -0.0593 S32: -1.1950 S33: 0.3097 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 1 D 4 REMARK 3 ORIGIN FOR THE GROUP (A): 68.6450 55.2420 48.7740 REMARK 3 T TENSOR REMARK 3 T11: 0.0127 T22: 0.0333 REMARK 3 T33: 0.3965 T12: -0.0204 REMARK 3 T13: -0.0097 T23: -0.0004 REMARK 3 L TENSOR REMARK 3 L11: 1.7704 L22: 8.3622 REMARK 3 L33: 33.0082 L12: 3.8300 REMARK 3 L13: 1.0034 L23: -6.3387 REMARK 3 S TENSOR REMARK 3 S11: -0.0981 S12: -0.0075 S13: 0.0150 REMARK 3 S21: 0.1035 S22: 0.1635 S23: 0.2318 REMARK 3 S31: 0.3048 S32: -0.2042 S33: -0.0654 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 401 B 401 REMARK 3 ORIGIN FOR THE GROUP (A): 70.0870 49.7820 58.9390 REMARK 3 T TENSOR REMARK 3 T11: 0.3343 T22: 0.3476 REMARK 3 T33: 0.3125 T12: -0.0020 REMARK 3 T13: 0.0435 T23: 0.0722 REMARK 3 L TENSOR REMARK 3 L11: 88.4259 L22: 187.7068 REMARK 3 L33: 121.9711 L12: -1.1598 REMARK 3 L13: -24.8594 L23: 31.7684 REMARK 3 S TENSOR REMARK 3 S11: 0.6004 S12: -1.0142 S13: -1.1977 REMARK 3 S21: 3.1746 S22: -1.9866 S23: 2.3429 REMARK 3 S31: 0.3984 S32: -1.5038 S33: 1.3863 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2I3H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039089. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR: WATER COOLED; REMARK 200 SAGITALLY FOCUSING 2ND CRYSTAL, REMARK 200 ROSENBAUM-ROCK VERTICAL FOCUSING REMARK 200 MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32349 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 38.5 REMARK 200 DATA REDUNDANCY IN SHELL : 0.70 REMARK 200 R MERGE FOR SHELL (I) : 0.40600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1.3 A STRUCTURE OF THE ML-IAP/XIAP PROTEIN BOUND REMARK 200 TO A DIFFERENT PEPTIDOMIMETIC, WITH THE LIGAND AND SURROUNDING REMARK 200 WATERS REMOVED REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LITHIUM SULFATE, PEG 3350, BIS-TRIS, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.93800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.77050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.77050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.46900 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.77050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.77050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.40700 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.77050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.77050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.46900 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.77050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.77050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.40700 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 36.93800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -51.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.87600 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.87600 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -41.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.87600 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.87600 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.87600 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 SER A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLY A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLY A 57 REMARK 465 SER A 58 REMARK 465 HIS A 59 REMARK 465 MET A 60 REMARK 465 LEU A 61 REMARK 465 GLU A 62 REMARK 465 THR A 63 REMARK 465 GLU A 64 REMARK 465 GLU A 65 REMARK 465 GLU A 66 REMARK 465 GLU A 67 REMARK 465 GLU A 68 REMARK 465 GLU A 69 REMARK 465 GLY A 70 REMARK 465 ALA A 71 REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 THR A 74 REMARK 465 LEU A 75 REMARK 465 SER A 76 REMARK 465 ARG A 77 REMARK 465 LEU A 168 REMARK 465 THR A 169 REMARK 465 HIS A 170 REMARK 465 SER A 171 REMARK 465 LEU A 172 REMARK 465 MET B 40 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 SER B 43 REMARK 465 HIS B 44 REMARK 465 HIS B 45 REMARK 465 HIS B 46 REMARK 465 HIS B 47 REMARK 465 HIS B 48 REMARK 465 HIS B 49 REMARK 465 SER B 50 REMARK 465 SER B 51 REMARK 465 GLY B 52 REMARK 465 GLU B 53 REMARK 465 VAL B 54 REMARK 465 PRO B 55 REMARK 465 ARG B 56 REMARK 465 GLY B 57 REMARK 465 SER B 58 REMARK 465 HIS B 59 REMARK 465 MET B 60 REMARK 465 LEU B 61 REMARK 465 GLU B 62 REMARK 465 THR B 63 REMARK 465 GLU B 64 REMARK 465 GLU B 65 REMARK 465 GLU B 66 REMARK 465 GLU B 67 REMARK 465 GLU B 68 REMARK 465 GLU B 69 REMARK 465 GLY B 70 REMARK 465 ALA B 71 REMARK 465 GLY B 72 REMARK 465 ALA B 73 REMARK 465 THR B 74 REMARK 465 LEU B 75 REMARK 465 SER B 76 REMARK 465 ARG B 77 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 156 CD NE CZ NH1 NH2 REMARK 480 GLU A 161 CG CD OE1 OE2 REMARK 480 GLU B 88 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OXT TRP D 4 O HOH D 172 1.55 REMARK 500 O HOH B 1028 O HOH B 1105 1.84 REMARK 500 OXT TRP C 4 O HOH C 169 1.95 REMARK 500 O HOH A 1003 O HOH A 1087 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1023 O HOH D 21 4564 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 119 -132.73 48.16 REMARK 500 GLN B 119 -142.52 47.94 REMARK 500 TYR B 128 -11.81 78.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 124 SG REMARK 620 2 CYS A 127 SG 106.7 REMARK 620 3 HIS A 144 NE2 99.1 118.3 REMARK 620 4 CYS A 151 SG 116.3 109.3 107.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 LI B1002 LI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 93 O REMARK 620 2 ASP B 96 OD1 115.3 REMARK 620 3 HIS B 115 ND1 114.5 99.3 REMARK 620 4 EDO B 301 O2 99.1 107.7 121.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 124 SG REMARK 620 2 CYS B 127 SG 108.2 REMARK 620 3 HIS B 144 NE2 100.4 127.7 REMARK 620 4 CYS B 151 SG 116.3 106.1 98.7 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTB B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TW6 RELATED DB: PDB REMARK 900 ML-IAP/XIAP CHIMERA BOUND TO A 9MER PEPTIDE DERIVED FROM SMAC REMARK 900 RELATED ID: 1OXN RELATED DB: PDB REMARK 900 WILDTYPE ML-IAP-BIR BOUND TO AEAVPWKSE PEPTIDE REMARK 900 RELATED ID: 1OXQ RELATED DB: PDB REMARK 900 WILDTYPE ML-IAP-BIR BOUND TO AVPIAQKSE (SMAC) PEPTIDE REMARK 900 RELATED ID: 1OY7 RELATED DB: PDB REMARK 900 WILDTYPE ML-IAP-BIR BOUND TO AEVVAVKSE PEPTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 FOR ENTITY 1 (CHAINS A AND B) RESIDUES 150, REMARK 999 160-168, AND 172 REPLACED WITH XIAP-BIR3 REMARK 999 HOMOLOGUES. DBREF 2I3H A 63 172 UNP Q96CA5 BIRC7_HUMAN 63 172 DBREF 2I3H B 63 172 UNP Q96CA5 BIRC7_HUMAN 63 172 DBREF 2I3H C 1 4 PDB 2I3H 2I3H 1 4 DBREF 2I3H D 1 4 PDB 2I3H 2I3H 1 4 SEQADV 2I3H MET A 40 UNP Q96CA5 INITIATING METHIONINE SEQADV 2I3H GLY A 41 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER A 42 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER A 43 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 44 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 45 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 46 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 47 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 48 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 49 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER A 50 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER A 51 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY A 52 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLU A 53 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H VAL A 54 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H PRO A 55 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H ARG A 56 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY A 57 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER A 58 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS A 59 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H MET A 60 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H LEU A 61 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLU A 62 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY A 150 UNP Q96CA5 SER 150 SEE REMARK 999 SEQADV 2I3H GLN A 160 UNP Q96CA5 ARG 160 SEE REMARK 999 SEQADV 2I3H GLU A 161 UNP Q96CA5 ASP 161 SEE REMARK 999 SEQADV 2I3H TYR A 162 UNP Q96CA5 PHE 162 SEE REMARK 999 SEQADV 2I3H ILE A 163 UNP Q96CA5 VAL 163 SEE REMARK 999 SEQADV 2I3H ASN A 164 UNP Q96CA5 HIS 164 SEE REMARK 999 SEQADV 2I3H ASN A 165 UNP Q96CA5 SER 165 SEE REMARK 999 SEQADV 2I3H ILE A 166 UNP Q96CA5 VAL 166 SEE REMARK 999 SEQADV 2I3H HIS A 167 UNP Q96CA5 GLN 167 SEE REMARK 999 SEQADV 2I3H LEU A 168 UNP Q96CA5 GLU 168 SEE REMARK 999 SEQADV 2I3H LEU A 172 UNP Q96CA5 GLN 172 SEE REMARK 999 SEQADV 2I3H MET B 40 UNP Q96CA5 INITIATING METHIONINE SEQADV 2I3H GLY B 41 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER B 42 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER B 43 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 44 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 45 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 46 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 47 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 48 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 49 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER B 50 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER B 51 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY B 52 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLU B 53 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H VAL B 54 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H PRO B 55 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H ARG B 56 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY B 57 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H SER B 58 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H HIS B 59 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H MET B 60 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H LEU B 61 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLU B 62 UNP Q96CA5 EXPRESSION TAG SEQADV 2I3H GLY B 150 UNP Q96CA5 SER 150 SEE REMARK 999 SEQADV 2I3H GLN B 160 UNP Q96CA5 ARG 160 SEE REMARK 999 SEQADV 2I3H GLU B 161 UNP Q96CA5 ASP 161 SEE REMARK 999 SEQADV 2I3H TYR B 162 UNP Q96CA5 PHE 162 SEE REMARK 999 SEQADV 2I3H ILE B 163 UNP Q96CA5 VAL 163 SEE REMARK 999 SEQADV 2I3H ASN B 164 UNP Q96CA5 HIS 164 SEE REMARK 999 SEQADV 2I3H ASN B 165 UNP Q96CA5 SER 165 SEE REMARK 999 SEQADV 2I3H ILE B 166 UNP Q96CA5 VAL 166 SEE REMARK 999 SEQADV 2I3H HIS B 167 UNP Q96CA5 GLN 167 SEE REMARK 999 SEQADV 2I3H LEU B 168 UNP Q96CA5 GLU 168 SEE REMARK 999 SEQADV 2I3H LEU B 172 UNP Q96CA5 GLN 172 SEE REMARK 999 SEQRES 1 A 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 A 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 A 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 A 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 A 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 A 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 A 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 A 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 A 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 A 133 HIS SER LEU SEQRES 1 B 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 B 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 B 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 B 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 B 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 B 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 B 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 B 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 B 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 B 133 HIS SER LEU SEQRES 1 C 4 ALA VAL PRO TRP SEQRES 1 D 4 ALA VAL PRO TRP HET ZN A1001 1 HET ZN B1001 1 HET LI B1002 1 HET BTB B 401 14 HET EDO B 301 4 HET EDO B 302 4 HETNAM ZN ZINC ION HETNAM LI LITHIUM ION HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETNAM EDO 1,2-ETHANEDIOL HETSYN BTB BIS-TRIS BUFFER HETSYN EDO ETHYLENE GLYCOL FORMUL 5 ZN 2(ZN 2+) FORMUL 7 LI LI 1+ FORMUL 8 BTB C8 H19 N O5 FORMUL 9 EDO 2(C2 H6 O2) FORMUL 11 HOH *233(H2 O) HELIX 1 1 PHE A 81 GLY A 85 5 5 HELIX 2 2 SER A 86 SER A 93 1 8 HELIX 3 3 PRO A 104 ALA A 111 1 8 HELIX 4 4 ASP A 139 PHE A 148 1 10 HELIX 5 5 CYS A 151 GLY A 159 1 9 HELIX 6 6 GLY A 159 HIS A 167 1 9 HELIX 7 7 PHE B 81 GLY B 85 5 5 HELIX 8 8 SER B 86 SER B 93 1 8 HELIX 9 9 PHE B 94 TRP B 97 5 4 HELIX 10 10 PRO B 104 ALA B 111 1 8 HELIX 11 11 ASP B 139 PHE B 148 1 10 HELIX 12 12 CYS B 151 GLY B 159 1 9 HELIX 13 13 GLY B 159 LEU B 172 1 14 SHEET 1 A 4 PHE A 113 HIS A 115 0 SHEET 2 A 4 VAL A 122 CYS A 124 -1 O ARG A 123 N PHE A 114 SHEET 3 A 4 GLY A 130 GLN A 132 -1 O LEU A 131 N VAL A 122 SHEET 4 A 4 VAL C 2 PRO C 3 -1 O VAL C 2 N GLN A 132 SHEET 1 B 4 PHE B 113 HIS B 115 0 SHEET 2 B 4 VAL B 122 CYS B 124 -1 O ARG B 123 N PHE B 114 SHEET 3 B 4 GLY B 130 GLN B 132 -1 O LEU B 131 N VAL B 122 SHEET 4 B 4 VAL D 2 PRO D 3 -1 O VAL D 2 N GLN B 132 LINK SG CYS A 124 ZN ZN A1001 1555 1555 2.34 LINK SG CYS A 127 ZN ZN A1001 1555 1555 2.34 LINK NE2 HIS A 144 ZN ZN A1001 1555 1555 2.09 LINK SG CYS A 151 ZN ZN A1001 1555 1555 2.31 LINK O SER B 93 LI LI B1002 1555 1555 1.87 LINK OD1 ASP B 96 LI LI B1002 1555 1555 1.82 LINK ND1 HIS B 115 LI LI B1002 1555 1555 1.98 LINK SG CYS B 124 ZN ZN B1001 1555 1555 2.34 LINK SG CYS B 127 ZN ZN B1001 1555 1555 2.33 LINK NE2 HIS B 144 ZN ZN B1001 1555 1555 2.11 LINK SG CYS B 151 ZN ZN B1001 1555 1555 2.33 LINK O2 EDO B 301 LI LI B1002 1555 1555 1.89 SITE 1 AC1 4 CYS A 124 CYS A 127 HIS A 144 CYS A 151 SITE 1 AC2 4 CYS B 124 CYS B 127 HIS B 144 CYS B 151 SITE 1 AC3 4 SER B 93 ASP B 96 HIS B 115 EDO B 301 SITE 1 AC4 9 HOH A1060 PRO B 82 LYS B 146 TRP B 147 SITE 2 AC4 9 HIS B 170 HOH B1011 HOH B1033 HOH B1086 SITE 3 AC4 9 HOH B1098 SITE 1 AC5 9 SER A 93 HOH A1073 SER B 93 ASP B 96 SITE 2 AC5 9 HIS B 115 GLY B 117 LI B1002 HOH B1018 SITE 3 AC5 9 HOH B1101 SITE 1 AC6 5 CYS B 127 PHE B 148 PRO B 149 GLY B 150 SITE 2 AC6 5 HOH B1077 CRYST1 87.541 87.541 73.876 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011423 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013536 0.00000